Featured Videos |view more
MUSC neurosurgeon Nathan Rowland, M.D., Ph.D., shares technical details and sample footage of a unique cranial reconstruction case.
Sunil Patel, M.D., the chair of neurosurgery at MUSC, discusses trigeminal neuralgia, a rare condition that causes intense pain in the face when no painful stimuli are present, and its surgical treatment.
Alexander Vandergrift, M.D., a neurosurgeon at MUSC, describes removing a nonfunctioning pituitary tumor from a patient through endonasal resection using an endoscope.
Featured Articles and Documents |view more
Site-targeted inhibitor for complement system reduces negative effects of brain hemorrhaging in premature infants
Alzheimer’s disease is an enormous problem that, with an aging population, will only become bigger.
MUSC researchers prove motor cortex is successful target for pain and addiction treatment, which suggests an overlooked area of the brain in TMS treatment
MUSC Health’s telestroke program gives patients a better chance of recovery by reducing time to treatment
EyeStat, a portable, lightweight device for measuring the natural blink reflex, received clearance by the U.S. Food and Drug Administration (FDA) in December 2019.
MUSC Health Neurosciences ranks first in the Southeast and second in the country in National Institutes of Health neuroscience research funding. It places researchers and clinicians at each other’s side in an effort to realize the clinical promise of cutting-edge research. As a consistent leader in neuroscience advances, MUSC Health is: